Breaking News Instant updates and real-time market news.

ATVI

Activision Blizzard

$55.60

0.01 (0.02%)

, EA

Electronic Arts

$96.78

0.56 (0.58%)

05:22
10/18/19
10/18
05:22
10/18/19
05:22

NPD video game sales down 6% for Q3, says Piper Jaffray

NPD video game sales data is down 6% for the full September quarter, Piper Jaffray analyst Michael Olson tells investors in a research note. Electronic Arts' (EA) Madden NFL was the top selling title for all of Q3, followed closely by Take-Two (TTWO) titles NBA 2K20 and Borderlands 3, Olson says. He views the NPD results are neutral for Activision Blizzard (ATVI), given no major launches for the quarter. The analyst maintains Overweight ratings on Activision, EA and Take Two.

ATVI

Activision Blizzard

$55.60

0.01 (0.02%)

EA

Electronic Arts

$96.78

0.56 (0.58%)

TTWO

Take-Two

$122.71

1.59 (1.31%)

  • 18

    Oct

  • 29

    Oct

  • 07

    Nov

  • 07

    Nov

  • 13

    Nov

  • 21

    Nov

ATVI Activision Blizzard
$55.60

0.01 (0.02%)

10/03/19
KEYB
10/03/19
NO CHANGE
KEYB
KeyBanc views Activision Blizzard's Call of Duty: Mobile datapoints as positive
KeyBanc analyst Tyler Parker notes that according to Sensortower, Activivision's "Call of Duty: Mobile" has accumulated over $2M in spend and 20M downloads within the first few days of release. This is relatively in line or above other battle royale games, or mobile games that have stemmed from established IP on console, he contends. The analyst continues to believe that the game has significant potential as a premium mobile game experience, and views initial datapoints as positive relative to his expectations of $20M for Q4.
10/11/19
RHCO
10/11/19
NO CHANGE
Target $59
RHCO
Buy
Activision Blizzard price target raised to $59 from $56 at SunTrust
SunTrust analyst Matthew Thornton says he expects "solid" Q3 reports from the video game companies, with Activision Blizzard (ATVI) having the most upside vs. consensus, driven by WoW and model EPS and revenue at 30c and $1.27B. The analyst raised his price target to $59 from $56 and maintains a Buy rating. He expects "at least" an in-line Q2 report from Electronic Arts (EA) and expects full-year guidance to be raised, though not likely to where the consensus is yet with half the fiscal year still to go. Thornton sees Take-Two's (TTWO) Q2 results to be slightly above the consensus, but sees initial Q3 guidance to be slightly below consensus, citing the company's "typical conservatism." He expects Take-Two to raise full-year guidance, though not likely to where the consensus is yet.
10/14/19
COWN
10/14/19
NO CHANGE
Target $48
COWN
Market Perform
Activision Blizzard player boycott impacting Hearthstone revenue, says Cowen
Cowen analyst Doug Creutz noted after the company's decision to suspend a player for pro-Hong Kong comments, there have been calls online to boycott the company. The analyst said data suggests that US bookings for the game are at least 18-23% lower than they would have been without the boycott, with varying impacts in other countries. Creutz maintains his Market Perform rating and $48 price target on Activision Blizzard shares.
10/15/19
SBSH
10/15/19
NO CHANGE
Target $55
SBSH
Neutral
Activision Blizzard price target raised to $55 from $47 at Citi
Citi analyst Jason Bazinet raised his price target for Activision Blizzard to $55 from $47 citing the strong October 1 launch of Call of Duty: Mobile. A few days following the release, Activision disclosed that the game had garnered over 35M downloads, Bazinet tells investors in a research note. The analyst "modestly" raised his revenue estimates for Activision and rolled forward his valuation framework from 2020 to 2021. However, he keeps a Neutral rating on the shares, saying both consensus forecasts and Activision's valuation reflect its growth.
EA Electronic Arts
$96.78

0.56 (0.58%)

10/03/19
KEYB
10/03/19
NO CHANGE
KEYB
Sector Weight
Electronic Arts 'Apex Legends' looks to be slowing, says KeyBanc
KeyBanc analyst Tyler Parker believes Electronic Arts' Season 2 of Apex Legends has not rejuvenated the player base materially and there is risk to Apex guidance of $300M-$400M in fiscal year 2020. The analyst is lowering his estimates for EA slightly as he brings Apex to $275M for 2020 from $365M. Parker reiterates a Sector Weight rating on the shares.
10/02/19
BARD
10/02/19
NO CHANGE
Target $114
BARD
Outperform
Electronic Arts seeing positive initial reaction of Apex 3 launch, says Baird
Baird analyst Colin Sebastian noted there were concerns over electronic Arts' Apex usage trends following backlash over monetization during season 2. The analyst said h is encouraged by what appears to be the positive initial reaction to season 3, and at this point remains comfortable with his full year revenue estimates as well as with his above consensus Q3 estimates. Sebastian reiterated his Outperform rating and $114 price target on Electronic Arts shares.
09/18/19
PIPR
09/18/19
NO CHANGE
Target $62
PIPR
Overweight
Activision Blizzard price target raised to $62 from $55 at Piper Jaffray
Piper Jaffray analyst Michael Olson raised his price target for Activision Blizzard (ATVI) to $62 from $55 saying he continues to view the company as the best positioned video game publisher into 2020. His ongoing confidence in Activision, even after the recent run-up in shares, is due to a "favorable catalyst path" into 2020. This began with the recent launch of World of Warcraft Classic and continues with multiple new or updated titles coming over the next four-to-five quarters, Olson tells investors in a research note. The analyst also keeps an Overweight rating on Activision Blizzard, Electronic Arts (EA) and Take-Two Interactive (TTWO).
TTWO Take-Two
$122.71

1.59 (1.31%)

10/17/19
MKMP
10/17/19
NO CHANGE
MKMP
Buy
MKM Partners says 'no need to panic' about Take-Two's 'Borderlands 3' price cut
MKM Partners analyst Eric Handler told investors in a research note before the open that there is "no need to panic" about Take-Two's latest game "Borderlands 3" going on sale. Handler said that he received a number of questions yesterday from investors wondering if the game was underperforming expectations since certain retailers lowered the price for the game to $45 from $60. The analyst said that, in his view, there was "a lot of faulty analysis" assessing the performance of "Borderlands 3," adding that there has not been very much information about unit sales since Take-Two issued a press release late last month which stated the title had sold-in over 5M units during its first five days of launch and "exceeded" management's expectations. Handler, who has a Buy rating and $142 on Take-Two, believes that "Borderlands 3" has continued to sell well and that the retail price cuts are "marketing driven" instead of performance related.
10/04/19
SPHN
10/04/19
NO CHANGE
Target $145
SPHN
Overweight
Stephens sees 'robust demand' for Take-Two's 'Red Dead 2' on PC
Stephens analyst Jeff Cohen reiterated an Overweight rating and $145 on Take-Two after the game maker's Rockstar unit confirmed that its popular game "Red Dead Redemption 2" will be coming to PC on November 5, exclusively on the developer's own PC launcher. Cohen said that with the release date for the port being confirmed, five months of "Red Dead" PC sales will be captured in fiscal 2020. He assumes in his model 2.5M units for the PC port in FY20, which "could wind up being conservative" as he had previously assumed the launch would come later in the quarter. The analyst said he continues to believe there is "robust demand" for the PC release and thinks that the release can also boost interest in "Red Dead Online" moving forward.
10/03/19
NOMU
10/03/19
INITIATION
Target $135
NOMU
Neutral
Take-Two initiated with a Neutral at Nomura Instinet
Nomura Instinet analyst Andrew Marok started Take-Two Interactive Software with a Neutral rating and $135 price target. The analyst believes the company's company's success in recent releases "has been undeniable," and he likes its prospects for pipeline expansion. However, he finds Take-Two shares are fairly valued at current levels.

TODAY'S FREE FLY STORIES

21:55
12/09/19
12/09
21:55
12/09/19
21:55
General news
Treasury Market Summary »

Treasury Market Summary:…

AUPH

Aurinia Pharmaceuticals

$15.76

0.31 (2.01%)

21:03
12/09/19
12/09
21:03
12/09/19
21:03
Syndicate
Aurinia Pharmaceuticals 11.1M share Secondary priced at $15.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

GDI

Gardner Denver

$33.90

-0.19 (-0.56%)

20:08
12/09/19
12/09
20:08
12/09/19
20:08
Downgrade
Gardner Denver rating change at BTIG »

Gardner Denver downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDI

Gardner Denver

$33.90

-0.19 (-0.56%)

19:56
12/09/19
12/09
19:56
12/09/19
19:56
Downgrade
Gardner Denver rating change at BTIG »

Gardner Denver downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DTCWY

Deutsche Wohnen

$0.00

(0.00%)

19:50
12/09/19
12/09
19:50
12/09/19
19:50
Downgrade
Deutsche Wohnen rating change at Goldman Sachs »

Deutsche Wohnen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEGXF

Segro

$0.00

(0.00%)

19:49
12/09/19
12/09
19:49
12/09/19
19:49
Downgrade
Segro rating change at Goldman Sachs »

Segro downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BORR

Borr Drilling

$6.60

0.46 (7.49%)

19:30
12/09/19
12/09
19:30
12/09/19
19:30
Initiation
Borr Drilling initiated at Goldman Sachs »

Borr Drilling initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSG

Inseego

$6.89

-0.05 (-0.72%)

19:26
12/09/19
12/09
19:26
12/09/19
19:26
Syndicate
Breaking Syndicate news story on Inseego »

Inseego files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTSV

Forty Seven

$30.44

16.04 (111.39%)

19:25
12/09/19
12/09
19:25
12/09/19
19:25
Conference/Events
Forty Seven to hold an investor event »

Investor Event will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

ARQL

ArQule

$19.71

10.035 (103.77%)

19:25
12/09/19
12/09
19:25
12/09/19
19:25
Conference/Events
ArQule »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

XNCR

Xencor

$41.41

0.39 (0.95%)

19:25
12/09/19
12/09
19:25
12/09/19
19:25
Conference/Events
Xencor to host analyst & investor meeting »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

ABR

Arbor Realty

$14.78

(0.00%)

19:20
12/09/19
12/09
19:20
12/09/19
19:20
Syndicate
Arbor Realty 6.5M share Spot Secondary priced at $14.14 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

STRM

Streamline Health

$1.25

-0.04 (-3.10%)

18:59
12/09/19
12/09
18:59
12/09/19
18:59
Hot Stocks
Streamline Health delaying Q3 results to resolve amortization charge »

Streamline Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLOK

NortonLifeLock

$25.43

-0.02 (-0.08%)

, INTC

Intel

$56.52

-0.28 (-0.49%)

18:55
12/09/19
12/09
18:55
12/09/19
18:55
Periodicals
McAfee weighs combination with NortonLifeLock, WSJ reports »

NortonLifeLock (NLOK) has…

NLOK

NortonLifeLock

$25.43

-0.02 (-0.08%)

INTC

Intel

$56.52

-0.28 (-0.49%)

AVGO

Broadcom

$314.49

-1.68 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

  • 19

    Dec

  • 23

    Jan

TGTX

TG Therapeutics

$9.28

2.17 (30.52%)

18:55
12/09/19
12/09
18:55
12/09/19
18:55
Conference/Events
TG Therapeutics to host investor & analyst meeting »

Investor & Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

NTNX

Nutanix

$33.87

-0.725 (-2.10%)

18:41
12/09/19
12/09
18:41
12/09/19
18:41
Hot Stocks
Nutanix CEO: We are transitioning to a subscription-based model »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 13

    Dec

  • 16

    Dec

SFIX

Stitch Fix

$25.17

1.04 (4.31%)

, MDB

MongoDB

$131.03

-0.19 (-0.14%)

18:33
12/09/19
12/09
18:33
12/09/19
18:33
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Stitch…

SFIX

Stitch Fix

$25.17

1.04 (4.31%)

MDB

MongoDB

$131.03

-0.19 (-0.14%)

PHR

Phreesia

$29.01

-0.09 (-0.31%)

CDMO

Avid Bioservices

$5.85

0.05 (0.86%)

MTN

Vail Resorts

$231.30

-1.43 (-0.61%)

TOL

Toll Brothers

$41.40

0.515 (1.26%)

EQ

Equillium

$4.00

-0.03 (-0.74%)

SUPN

Supernus

$22.69

-0.145 (-0.63%)

A

Agilent

$81.68

-0.545 (-0.66%)

HEPA

Hepion Pharmaceuticals

$5.61

0.4 (7.68%)

ROAD

Construction Partners

$20.56

0.66 (3.32%)

CASY

Casey's General Stores

$175.33

-0.47 (-0.27%)

CHWY

Chewy

$24.17

-0.76 (-3.05%)

LVGO

Livongo Health

$27.40

-0.6 (-2.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 11

    Dec

  • 12

    Dec

  • 18

    Dec

  • 19

    Dec

BLUE

Bluebird Bio

$76.72

-2.79 (-3.51%)

, BMY

Bristol-Myers

$61.32

1.38 (2.30%)

18:24
12/09/19
12/09
18:24
12/09/19
18:24
Hot Stocks
Bluebird Bio, Bristol-Myers present update on Phase 1 study of bb21217 »

Bluebird bio (BLUE) and…

BLUE

Bluebird Bio

$76.72

-2.79 (-3.51%)

BMY

Bristol-Myers

$61.32

1.38 (2.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 11

    Dec

BA

Boeing

$351.25

-2.74 (-0.77%)

18:22
12/09/19
12/09
18:22
12/09/19
18:22
Periodicals
Former Boeing employee Pierson to testify at U.S. House hearing, Reuters says »

An ex-Boeing employee who…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

OXY

Occidental Petroleum

$37.34

-0.07 (-0.19%)

18:21
12/09/19
12/09
18:21
12/09/19
18:21
Hot Stocks
Occidental Petroleum director buys 12.9K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

OXY

Occidental Petroleum

$37.34

-0.07 (-0.19%)

18:14
12/09/19
12/09
18:14
12/09/19
18:14
Hot Stocks
Occidental Petroleum director buys 10K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

EDIT

Editas Medicine

$30.34

-0.6 (-1.94%)

18:02
12/09/19
12/09
18:02
12/09/19
18:02
Hot Stocks
Editas Medicine announces in vivo proof-of-concept data for EDIT-301 »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSB

Mesabi Trust

$23.93

0.71 (3.06%)

, CLF

Cleveland-Cliffs

$8.52

0.38 (4.67%)

17:56
12/09/19
12/09
17:56
12/09/19
17:56
Hot Stocks
Mesabi Trust initiates arbitration against Northshore Mining, Cleveland-Cliffs »

The Trustees of Mesabi…

MSB

Mesabi Trust

$23.93

0.71 (3.06%)

CLF

Cleveland-Cliffs

$8.52

0.38 (4.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FFBC

First Financial Bancorp

$24.67

0.12 (0.49%)

17:51
12/09/19
12/09
17:51
12/09/19
17:51
Hot Stocks
First Financial Bancorp chairman Davis sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRE

Green Plains

$14.26

-0.49 (-3.32%)

17:47
12/09/19
12/09
17:47
12/09/19
17:47
Hot Stocks
Green Plains CEO Todd Becker sold over 607K in company shares »

Green Plains CEO Todd…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.